NEJM Catalyst analysis takes CivicaScript’s mission from proof of concept to proof; approach holds potential to transform the pharmaceutical supply chain LEHI, Utah, May 21, 2025 /PRNewswire/ — A new report in The New England Journal of Medicine Catalyst shows that CivicaScript’s®…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
